A calcium-stimulated serine protease from monkey brain degrades the β-amyloid precursor protein

[1]  S. Sisodia.  Secretion of the β‐Amyloid Precursor Protein a , 1992 .

[2]  P. Greengard,et al.  Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B. Ghetti,et al.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. , 1991, Science.

[4]  R. Cotter,et al.  Secretion of the β/A4 amyloid precursor protein: Identification of a cleavage site in cultured mammalian cells , 1991 .

[5]  J. Wegiel,et al.  Spatial relationships between astrocytes and classical plaque components , 1991, Neurobiology of Aging.

[6]  M. Beal,et al.  An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Morley,et al.  Amnestic effects in mice of four synthetic peptides homologous to amyloid beta protein from patients with Alzheimer disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Selkoe.  The molecular pathology of Alzheimer's disease , 1991, Neuron.

[9]  V. Lee,et al.  Comparative epitope analysis of neuronal cytoskeletal proteins in Alzheimer's disease senile plaque neurites and neuropil threads. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[10]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[11]  P. Tempst,et al.  A calcium-activated protease from Alzheimer's disease brain cleaves at the N-terminus of the amyloid beta-protein. , 1991, Biochemical and biophysical research communications.

[12]  M. Ball,et al.  Beta-amyloid from Alzheimer disease brains inhibits sprouting and survival of sympathetic neurons. , 1991, Biochemical and biophysical research communications.

[13]  C. Cotman,et al.  β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage , 1990, Brain Research.

[14]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[15]  K. Yoshikawa,et al.  Formation of amyloid-like fibrils in COS cells overexpressing part of the Alzheimer amyloid protein precursor , 1990, Nature.

[16]  P. Tempst,et al.  Facile and sensitive assay for monitoring proteolytic activities with defined specificities: studies on amyloid beta-protein processing in Alzheimer's disease. , 1990, Peptide research.

[17]  T. Oltersdorf,et al.  Cleavage of amyloid beta peptide during constitutive processing of its precursor. , 1990, Science.

[18]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[19]  C. Finch,et al.  Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. , 1990, Science.

[20]  D. Price,et al.  Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.

[21]  E. Bird,et al.  Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin , 1990, Brain Research.

[22]  R. Nelson,et al.  Clipsin, a chymotrypsin-like protease in rat brain which is irreversibly inhibited by alpha-1-antichymotrypsin. , 1990, Journal of Biological Chemistry.

[23]  S. Younkin,et al.  Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR , 1990, Neuron.

[24]  D. Price,et al.  α1-Antichymotrypsin is present together with the β-protein in monkey brain amyloid deposits , 1989, Neuroscience.

[25]  J. Kimura,et al.  Tissue-specific expression of three types of β-protein precursor mRNA: Enhancement of protease inhibitor-harboring types in Alzheimer's disease brain , 1989 .

[26]  Carl W. Cotman,et al.  Protease nexin-II, a potent anti-chymotrypsin, shows identity to amyloid β-protein precursor , 1989, Nature.

[27]  Robert B. Nelson,et al.  Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage , 1989, Neuron.

[28]  L. Villa-komaroff,et al.  Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. , 1989, Science.

[29]  Steven A. Johnson,et al.  APP-695 transcript prevalence is selectively reduced during Alzheimer's disease in cortex and hippocampus but not in cerebellum , 1989, Neurobiology of Aging.

[30]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[31]  G. Cole,et al.  Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein. , 1988, Science.

[32]  D. Selkoe,et al.  Immunochemical identification of the serine protease inhibitor α 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease , 1988, Cell.

[33]  L. Villa-komaroff,et al.  Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease , 1988, Nature.

[34]  M. Mishkin,et al.  Age differences in recognition memory of the rhesus monkey (Macaca mulatta) , 1987, Neurobiology of Aging.

[35]  D. Price,et al.  Conservation of brain amyloid proteins in aged mammals and humans with Alzheimer's disease. , 1987, Science.

[36]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[37]  D. Selkoe,et al.  Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease , 1986, Journal of neurochemistry.

[38]  D. Price,et al.  Senile plaques in cortex of aged normal monkeys , 1985, Brain Research.

[39]  A. Bhown,et al.  Isolation, characterization, and amino-terminal amino acid sequence analysis of human neutrophil cathepsin G from normal donors. , 1985, Analytical biochemistry.

[40]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[42]  M. Colonnier,et al.  Postnatal changes in the number of astrocytes, oligodendrocytes, and microglia in the visual cortex (area 17) of the macaque monkey: A stereological analysis in normal and monocularly deprived animals , 1982, The Journal of comparative neurology.

[43]  K. Beyreuther,et al.  Molecular biology of Alzheimer's disease. , 1989, Annual review of biochemistry.